Axonics R20 Post-Market Clinical Follow-up (PMCF) Study for the Indication of Fecal Incontinence

Part of paid clinical trials in Houston, Texas.

Sponsor
Axonics, Inc.
Study ID
NCT07499258
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Fecal Incontinence

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Axonics SNM System INS Model 5101 (R20) — DEVICE
    Participants treated with the rechargeable Axonics SNM System Model 5101 also referred to as R20. Commercial devices used in this study are within their intended use as described in each geography's approved instructions for use.

Study Details

Single-Arm, multi-center, prospective, open-label registry study for commercially available rechargeable implantable neurostimulator (INS model 5101); also referred to as R20.

Key Dates

Start date
Jun 30, 2026
Status verified
May 2026
Primary completion
Dec 31, 2027
Completion
Dec 31, 2029

Study Design

Enrollment
55 participants (estimated)

Arms

  • Arm: Fecal Incontinence
    Participants with the Axonics SNM System Model 5101 and followed up regarding their fecal incontinence symptoms.

Primary Outcome Measure

Performance/effectiveness - Improvement in Quality of Life scoring (FI) [ Time Frame: 3 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Houston ColonHoustonTexas77030
Jimena Alcocer-Barrios
[email protected]
713-790-0600
Eric M. Haas, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Houston, TX

By research site
Houston Colon· Houston, TX

Related Studies